14 Nov 2022 11:46
JPMORGAN ELECT PLC (the 'Company') |
|
Legal Entity Identifier: 549300FIUYKKL39ILD07 | |
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 October 2022 | |
Managed Growth portfolio |
|
JPMorgan American Inv Trust | 14.8% |
JPMorgan Claverhouse Inv Trust | 8.2% |
JPM UK Equity Plus C | 7.9% |
Finsbury Growth & Income | 7.4% |
JPMorgan UK Dynamic C | 6.9% |
JPMorgan US Equity All Capital C | 6.3% |
JPMorgan US Value Fund | 4.1% |
Murray Income Trust | 3.6% |
JPMorgan US Select Equity C | 3.5% |
Fidelity | 3.3% |
Total | 66.0% |
Excludes Investments in Liquidity stocks | |
Managed Income portfolio |
|
Shell | 9.0% |
AstraZeneca | 7.7% |
BP | 6.2% |
Glencore | 4.0% |
British American Tobacco | 4.0% |
Barclays | 3.1% |
GSK | 3.1% |
BAE Systems Plc | 2.6% |
OSB | 2.6% |
Unilever | 2.4% |
Total | 44.6% |
Excludes Investments in Liquidity stocks | |
* Based on invested portfolio | |
Name of contact and telephone number for queries: | |
Paul Ainger 0044 207 742 6524 | |
Name of authorised company official responsible for making this notification: | |
Priyanka Vijay Anand 0044 203 493 1504 - Company Secretary | |
Date: 14 November 2022 | |